Selvita heads towards new development phase. Corporate and leadership changes, along with the purchase of a plot of land for further organic growth, as a starting point for new development strategy

/PRNewswire/ -- Selvita (WSE: SLV) – one of the largest preclinical contract research organizations in Europe, announced today changes to its leadership and...

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Zagreb ,Grad ,Croatia ,Poland ,Warsaw ,L67 ,American ,British ,Miroslawa Zydron ,Boguslaw Sieczkowski ,Milosz Gruca ,Contract Research Organization ,Selvita Group ,Chemistry Department Director ,Warsaw Stock Exchange ,Adrijana Vinter ,Global Head ,Drug Discovery ,Selvita Management ,Managing Director ,Chief Commercial Officer ,Executive Vice President ,North American ,Chief Operating Officer ,Chemistry Department ,Artificial Intelligence ,San Francisco Bay Area ,Selvita ,